Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Intranasal Insulin on LH in Men
NCT02154477Phase 2Completed
- Sponsor
- Texas Tech University Health Sciences Center
- Start
- Dec 2014
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Generex Oral-lyn in hypogonadotropic hypogonadism (HH), sponsored by Texas Tech University Health Sciences Center. Primary endpoint: Luteinizing Hormone at 4 hours. Started Dec 2014; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT02154477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02154477.